96027-74-6Relevant academic research and scientific papers
Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives
Waldhauser, Katri Maria,Toeroek, Michael,Ha, Huy-Riem,Thomet, Urs,Konrad, Daniel,Brecht, Karin,Follath, Ferenc,Kraehenbuehl, Stephan
, p. 1413 - 1423 (2006)
The aim of this work was to compare hepatocellular toxicity and pharmacological activity of amiodarone (2-n-butyl-3-[3,5 diiodo-4- diethylaminoethoxybenzoyl]-benzofuran; B2-O-Et-N-diethyl) and of eight amiodarone derivatives. Three amiodarone metabolites
Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites
Snead, Aaron N.,Miyakawa, Motonori,Tan, Edwin S.,Scanlan, Thomas S.
supporting information; experimental part, p. 5920 - 5922 (2009/05/31)
Amiodarone (Cordarone, Wyeth-Ayerst Pharmaceuticals) is a clinically available drug used to treat a wide variety of cardiac arrhythmias. We report here the synthesis and characterization of a panel of potential amiodarone metabolites that have significant structural similarity to thyroid hormone and its metabolites the iodothyronamines. Several of these amiodarone derivatives act as specific agonists of the G protein-coupled receptor (GPCR) trace amine-associated receptor 1 (TAAR1). This result demonstrates a novel molecular target for amiodarone derivatives with potential clinical significance.
Pharmaceutical and veterinary compositions for the treatment of ischemic cardiac disorders
-
, (2008/06/13)
Pharmaceutical and veterinary compositions having as essential active ingredient at least one benzofuran derivative of the general formula: STR1 or a pharmaceutically acceptable acid addition salt thereof in which R represents an amino, monoethylamino or diethylamino radical and X1 and X2 represent hydrogen or iodine with the proviso that when R represents diethylamino X1 and X2 are different. These compositions are useful for the treatment of ischemic cardiac disorders.
